SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000593
Filing Date
2019-07-31
Accepted
2019-07-31 06:10:19
Documents
13
Period of Report
2019-07-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv525888_ex8-k.htm   iXBRL 8-K 25856
2 EXHIBIT 99.1 tv525888_ex99-1.htm EX-99.1 109918
  Complete submission text file 0001410578-19-000593.txt   317341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20190731.xsd EX-101.SCH 3184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20190731_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20190731_pre.xml EX-101.PRE 21957
6 EXTRACTED XBRL INSTANCE DOCUMENT tv525888_ex8-k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 19987242
SIC: 2834 Pharmaceutical Preparations